Follow the 테라젠이텍스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has published 1 reports. Market capitalisation: €87.1bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 테라젠이텍스. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.